CAD031, a more active derivative of the Alzheimer’s disease (AD) targeting agent J147, exhibits neuroprotective and memory-enhancing properties. It has been shown to enhance memory, improve dendritic structure, and stimulate cell division in the germinal zone of aged mice brains. Additionally, CAD031 demonstrates greater efficacy than J147 in human neural stem cell assays [1].